Pan-Omics, the comprehensive integration of multiple omics to provide a complete molecular and functional profile of biological systems.
Our world-class team uses the latest technology to interrogate complex biological systems through spatially defined quantification of numerous biomolecules, to create a clear understanding of the microenvironment.
- Genomics – We decipher the genetic foundation of disease by identifying mutations, structural variations, and genetic risk factors that influence drug response.
- Transcriptomics – We capture the spatial organization of the tissue transcriptome, essential for biomarker and drug target discovery. This is especially critical in heterogeneous tumors, where tumor-microenvironment interactions drive disease progression. Single-cell spatially resolved transcriptomics is key to understanding these complex dynamics.
- Proteomics – We map protein expression, modifications, and interactions at the cellular and tissue levels to better understand drug mechanisms and biomarker discovery.
- Metabolomics – We measuring metabolic changes to assess cellular responses to disease and treatment, providing insights into drug efficacy and toxicity.
- Lipidomics – We investigate lipid profiles, which play a key role in cellular signaling, membrane dynamics, and disease progression, to enhance biomarker discovery and therapeutic targeting.